A phase 1/2 study of oral panobinostat combined with melphalan for patients with relapsed or refractory multiple myelomaJames R. Berenson, Robert Vescio, Jeffrey Matous et al.|Annals of Hematology|2013Cited by 36
A phase I/II trial of melphalan (MEL) combined with panobinostat (PAN) for patients with relapsed or refractory (R/R) multiple myeloma (MM).Ori Yellin, Robert Vescio, James R. Berenson et al.|Journal of Clinical Oncology|2012Cited by 6